SB Pharmco Puerto Rico Inc. | GlaxoSmithKline | drug or medical equipment safety violation | 2010 | FDA | $750,000,000 |
GlaxoSmithKline Vaccines | GlaxoSmithKline | environmental violation | 2014 | EPA | $172,900 |
GlaxoSmithKline LLC | GlaxoSmithKline | environmental violation | 2014 | EPA | $317,550 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2005 | DOJ_CIVIL | $150,000,000 |
GlaxoSmithKline plc | GlaxoSmithKline | kickbacks and bribery | 2016 | SEC | $20,000,000 |
Block Drug Company Incorporated | GlaxoSmithKline | wage and hour violation | 2011 | WHD | $352,773 |
SmithKline Beecham | GlaxoSmithKline | False Claims Act and related | 2003 | DOJ_CIVIL | $47,000,000 |
GLAXO SMITH KLINE | GlaxoSmithKline | aviation safety violation | 2014 | FAA | $59,500 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2003 | MULTI-AG | $40,000,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2005 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,000,000 |
GlaxoSmithKline | GlaxoSmithKline | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2006 | GA-AG | $418,952 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2012 | ID-AG | $2,600,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2011 | KS-AG | $4,250,000 |
GlaxoSmithKline | GlaxoSmithKline | off-label or unapproved promotion of medical products | 2010 | KY-AG | $3,700,000 |
GlaxoSmithKline | GlaxoSmithKline | off-label or unapproved promotion of medical products | 2009 | KY-AG | $661,860 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2012 | LA-AG | $10,000,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | drug or medical equipment safety violation | 2012 | MULTI-AG | $90,000,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $70,000,000 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $14,000,000 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $3,500,000 |
GlaxoSmithKline, LLC | GlaxoSmithKline | drug or medical equipment safety violation | 2011 | MULTI-AG | $40,750,000 |
GlaxoSmithKline, LLC | GlaxoSmithKline | kickbacks and bribery | 2014 | MULTI-AG | $105,000,000 |
SB Pharmco Puerto Rico Inc. | GlaxoSmithKline | drug or medical equipment safety violation | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $163,560,000 |
SmithKline Beecham Corp. | GlaxoSmithKline | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $10,000,000 |
SmithKline Beecham Corp. | GlaxoSmithKline | False Claims Act and related | 2007 | TX-AG | $1,400,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | False Claims Act and related | 2019 | IL-AG | $54,653,931 |
GlaxoSmithKline Holdings (Americas) | GlaxoSmithKline | tax violations | 2006 | IRS | $3,400,000,000 |
GLAXOSMITHKLINE LLC | GlaxoSmithKline | environmental violation | 2016 | PA-ENV | $5,259 |
GlaxoSmithKline LLC | GlaxoSmithKline | environmental violation | 2015 | NY-ENV | $24,200 |
GlaxoSmithKline, LLC | GlaxoSmithKline | off-label or unapproved promotion of medical products | 2013 | MD-AG | $15,000,000 |
GlaxoSmithKline | GlaxoSmithKline | drug or medical equipment safety violation | 2010 | private lawsuit-federal | $770,000,000 |
GlaxoSmithKline | GlaxoSmithKline | drug or medical equipment safety violation | 2009 | private lawsuit-federal | $28,000,000 |
GlaxoSmithKline | GlaxoSmithKline | drug or medical equipment safety violation | 2008 | private lawsuit-federal | $40,000,000 |
GlaxoSmithKline | GlaxoSmithKline | drug or medical equipment safety violation | 2006 | private lawsuit-state | $63,833,148 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $175,000,000 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $75,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $35,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $49,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $150,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $21,500,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $70,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $92,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $100,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $65,000,000 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2023 | IN-AG | $1,270,000 |
GLAXOSMITHKLINE, LLC | GlaxoSmithKline | environmental violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $317,550 |
GLAXOSMITHKLINE VACCINES | GlaxoSmithKline | environmental violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $172,900 |
IMMUNOMEDICS, INC. EMPLOYEES' 401(K) SAVINGS PLAN | Gilead Sciences | benefit plan administrator violation | 2001 | EBSA | $10,001 |
Gilead Sciences | Gilead Sciences | False Claims Act and related | 2013 | LA-AG | $250,000 |
Gilead Sciences, Inc. | Gilead Sciences | False Claims Act and related | 2020 | DOJ_CIVIL | $97,000,000 |
Gilead Sciences | Gilead Sciences | price-fixing or anti-competitive practices | 2024 | private lawsuit-federal | $246,750,000 |
GILEAD SCIENCES | Gilead Sciences | workplace safety or health violation | 2000 | OSHA | $5,700 |
Endo Health Solutions Inc. | Endo International | off-label or unapproved promotion of medical products | 2014 | FDA | $192,700,000 |
Par Pharmaceutical Companies Inc. | Endo International | off-label or unapproved promotion of medical products | 2013 | FDA | $45,000,000 |
Endo Pharmaceuticals Inc. and Vintage Pharmaceuticals, LLC d/b/a Qualitest Pharmaceuticals | Endo International | drug or medical equipment safety violation | 2015 | USAO | $39,000,000 |
Dava Pharmaceuticals Inc. | Endo International | False Claims Act and related | 2012 | DOJ_CIVIL | $11,000,000 |
Dava Pharmaceuticals, Inc. | Endo International | False Claims Act and related | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $11,000,000 |
Endo Health Solution | Endo International | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $173,000,000 |
Endo Health Solutions | Endo International | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $39,000,000 |
Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. | Endo International | drug or medical equipment safety violation | 2016 | NY-AG | $200,000 |
Endo International plc | Endo International | price-fixing or anti-competitive practices | 2019 | MULTI-AG | $2,300,000 |
Endo Pharmaceuticals | Endo International | consumer protection violation | 2019 | CA-AG | $760,000 |
Endo Pharmaceuticals | Endo International | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
Par Pharmaceutical | Endo International | False Claims Act and related | 2013 | LA-AG | $6,000,000 |
Par Pharmaceutical Co. | Endo International | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Par Pharmaceutical Companies Inc. | Endo International | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,500,000 |
Par Pharmaceutical Cos., Inc. | Endo International | False Claims Act and related | 2011 | ID-AG | $1,700,000 |
Par Pharmaceutical Inc. | Endo International | False Claims Act and related | 2011 | KY-AG | $4,500,000 |
Par Pharmaceutical, Inc. | Endo International | False Claims Act and related | 2010 | MA-AG | $500,000 |
Par Pharmaceuticals, Inc. | Endo International | False Claims Act and related | 2011 | MULTI-AG | $154,000,000 |
Endo Pharmaceuticals | Endo International | Controlled Substances Act violation | 2020 | OK-AG | $8,750,000 |
Endo Health Solutions | Endo International | off-label or unapproved promotion of medical products | 2021 | NY-AG | $50,000,000 |
Endo International PLC | Endo International | drug or medical equipment safety violation | 2017 | private lawsuit-federal | $775,000,000 |
Endo Health Solutions Inc. | Endo International | product safety violation | 2017 | private lawsuit-federal | $15,500,000 |
Endo International PLC | Endo International | drug or medical equipment safety violation | 2014 | private lawsuit-federal | $830,000,000 |
Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. | Endo International | off-label or unapproved promotion of medical products | 2022 | FL-AG | $65,000,000 |
Endo Health Solutions and Endo Pharmaceuticals | Endo International | off-label or unapproved promotion of medical products | 2022 | FL-AG | $65,000,000 |
Endo Pharmaceuticals | Endo International | off-label or unapproved promotion of medical products | 2022 | CA-SFCA | $10,000,000 |
Endo International plc | Endo International | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $450,000,000 |
Endo Pharmaceuticals Inc. | Endo International | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $60,000,000 |
Endo Pharmaceuticals Inc. | Endo International | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $40,000,000 |
Endo Health Solutions Inc. | Endo International | drug or medical equipment safety violation | 2024 | DOJ_CIVIL | $464,900,000 |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | environmental violation | 2012 | EPA | $68,475 |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | environmental violation | 2011 | EPA | $300,000 |
Eli Lilly and Company | Eli Lilly | Foreign Corrupt Practices Act | 2012 | SEC | $29,398,734 |
Eli Lilly and Company | Eli Lilly | off-label or unapproved promotion of medical products | 2009 | FDA | $1,415,000,000 |
Eli Lilly and Company | Eli Lilly | off-label or unapproved promotion of medical products | 2005 | FDA | $36,000,000 |
Eli Lilly | Eli Lilly | off-label or unapproved promotion of medical products | 2010 | AR-AG | $18,500,000 |
Eli Lilly | Eli Lilly | off-label or unapproved promotion of medical products | 2010 | MS-AG | $18,500,000 |
Eli Lilly | Eli Lilly | False Claims Act and related | 2013 | LA-AG | $1,650,000 |
Eli Lilly | Eli Lilly | off-label or unapproved promotion of medical products | 2010 | LA-AG | $20,000,000 |
Eli Lilly & Co. | Eli Lilly | privacy violation | 2002 | MULTI-AG | $160,000 |
Eli Lilly and Co. | Eli Lilly | off-label or unapproved promotion of medical products | 2009 | CT-AG | $25,100,000 |
Eli Lilly and Co. | Eli Lilly | off-label or unapproved promotion of medical products | 2009 | ID-AG | $13,000,000 |
Eli Lilly and Company | Eli Lilly | off-label or unapproved promotion of medical products | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $361,828,456 |
Eli Lilly and Company | Eli Lilly | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | $62,000,000 |
Imclone Systems, Inc. | Eli Lilly | employment discrimination | 2005 | EEOC | $85,000 |
ELI LILLY & CO LTC | Eli Lilly | environmental violation | 2019 | IN-ENV | $45,000 |
Eli Lilly and Company | Eli Lilly | drug or medical equipment safety violation | 2007 | private lawsuit-federal | $500,000,000 |